Page last updated: 2024-11-02

pentamidine and Strongyloidiasis

pentamidine has been researched along with Strongyloidiasis in 1 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Strongyloidiasis: Infection with nematodes of the genus STRONGYLOIDES. The presence of larvae may produce pneumonitis and the presence of adult worms in the intestine could lead to moderate to severe diarrhea.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Soma, K1

Other Studies

1 other study available for pentamidine and Strongyloidiasis

ArticleYear
[Diagnosis and therapy of parasitic lung diseases].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, May-10, Volume: 80, Issue:5

    Topics: Humans; Lung Diseases, Parasitic; Pentamidine; Pneumocystis; Pneumonia, Pneumocystis; Pyrimethamine;

1991